nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Cefonicid—ALB—breast cancer	0.000311	0.234	CrCbGaD
Cefuroxime—Urinary tract infection—Epirubicin—breast cancer	0.00027	0.000271	CcSEcCtD
Cefuroxime—Neutropenia—Doxorubicin—breast cancer	0.00027	0.00027	CcSEcCtD
Cefuroxime—Dysuria—Doxorubicin—breast cancer	0.00027	0.00027	CcSEcCtD
Cefuroxime—Decreased appetite—Paclitaxel—breast cancer	0.00027	0.00027	CcSEcCtD
Cefuroxime—Hypersensitivity—Fluorouracil—breast cancer	0.000268	0.000269	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000268	0.000269	CcSEcCtD
Cefuroxime—Haemoglobin—Methotrexate—breast cancer	0.000268	0.000269	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000268	0.000268	CcSEcCtD
Cefuroxime—Haemorrhage—Methotrexate—breast cancer	0.000267	0.000267	CcSEcCtD
Cefuroxime—Hepatitis—Methotrexate—breast cancer	0.000267	0.000267	CcSEcCtD
Cefuroxime—Sweating—Epirubicin—breast cancer	0.000267	0.000267	CcSEcCtD
Cefuroxime—Arthralgia—Capecitabine—breast cancer	0.000266	0.000266	CcSEcCtD
Cefuroxime—Chest pain—Capecitabine—breast cancer	0.000266	0.000266	CcSEcCtD
Cefuroxime—Pain—Paclitaxel—breast cancer	0.000265	0.000266	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000264	0.000264	CcSEcCtD
Cefuroxime—Urinary tract disorder—Methotrexate—breast cancer	0.000263	0.000264	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Epirubicin—breast cancer	0.000263	0.000263	CcSEcCtD
Cefuroxime—Anaphylactic shock—Docetaxel—breast cancer	0.000263	0.000263	CcSEcCtD
Cefuroxime—Pruritus—Gemcitabine—breast cancer	0.000262	0.000263	CcSEcCtD
Cefuroxime—Nausea—Thiotepa—breast cancer	0.000262	0.000262	CcSEcCtD
Cefuroxime—Urethral disorder—Methotrexate—breast cancer	0.000262	0.000262	CcSEcCtD
Cefuroxime—Sinusitis—Epirubicin—breast cancer	0.000261	0.000261	CcSEcCtD
Cefuroxime—Diarrhoea—Mitoxantrone—breast cancer	0.00026	0.000261	CcSEcCtD
Cefuroxime—Diarrhoea—Irinotecan—breast cancer	0.00026	0.000261	CcSEcCtD
Cefuroxime—Agranulocytosis—Epirubicin—breast cancer	0.00026	0.00026	CcSEcCtD
Cefuroxime—Pruritus—Fluorouracil—breast cancer	0.000258	0.000258	CcSEcCtD
Cefuroxime—Thrombocytopenia—Docetaxel—breast cancer	0.000257	0.000258	CcSEcCtD
Cefuroxime—Drowsiness—Doxorubicin—breast cancer	0.000257	0.000258	CcSEcCtD
Cefuroxime—Infestation—Doxorubicin—breast cancer	0.000257	0.000258	CcSEcCtD
Cefuroxime—Infestation NOS—Doxorubicin—breast cancer	0.000257	0.000258	CcSEcCtD
Cefuroxime—Tachycardia—Docetaxel—breast cancer	0.000257	0.000257	CcSEcCtD
Cefuroxime—Skin disorder—Docetaxel—breast cancer	0.000255	0.000256	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000255	0.000255	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Paclitaxel—breast cancer	0.000254	0.000254	CcSEcCtD
Cefuroxime—Diarrhoea—Gemcitabine—breast cancer	0.000254	0.000254	CcSEcCtD
Cefuroxime—Renal failure—Doxorubicin—breast cancer	0.000253	0.000253	CcSEcCtD
Cefuroxime—Erythema multiforme—Methotrexate—breast cancer	0.000252	0.000253	CcSEcCtD
Cefuroxime—Dizziness—Irinotecan—breast cancer	0.000252	0.000252	CcSEcCtD
Cefuroxime—Haemoglobin—Epirubicin—breast cancer	0.000251	0.000251	CcSEcCtD
Cefuroxime—Stomatitis—Doxorubicin—breast cancer	0.000251	0.000251	CcSEcCtD
Cefuroxime—Jaundice—Doxorubicin—breast cancer	0.000251	0.000251	CcSEcCtD
Cefuroxime—Anorexia—Docetaxel—breast cancer	0.000251	0.000251	CcSEcCtD
Cefuroxime—Urinary tract infection—Doxorubicin—breast cancer	0.00025	0.00025	CcSEcCtD
Cefuroxime—Haemorrhage—Epirubicin—breast cancer	0.00025	0.00025	CcSEcCtD
Cefuroxime—Hepatitis—Epirubicin—breast cancer	0.00025	0.00025	CcSEcCtD
Cefuroxime—Diarrhoea—Fluorouracil—breast cancer	0.000249	0.00025	CcSEcCtD
Cefuroxime—Thrombocytopenia—Capecitabine—breast cancer	0.000249	0.00025	CcSEcCtD
Cefuroxime—Tachycardia—Capecitabine—breast cancer	0.000249	0.000249	CcSEcCtD
Cefuroxime—Skin disorder—Capecitabine—breast cancer	0.000247	0.000248	CcSEcCtD
Cefuroxime—Sweating—Doxorubicin—breast cancer	0.000247	0.000247	CcSEcCtD
Cefuroxime—Urinary tract disorder—Epirubicin—breast cancer	0.000247	0.000247	CcSEcCtD
Cefuroxime—Urticaria—Paclitaxel—breast cancer	0.000246	0.000247	CcSEcCtD
Cefuroxime—Hyperhidrosis—Capecitabine—breast cancer	0.000246	0.000246	CcSEcCtD
Cefuroxime—Abdominal pain—Paclitaxel—breast cancer	0.000245	0.000246	CcSEcCtD
Cefuroxime—Body temperature increased—Paclitaxel—breast cancer	0.000245	0.000246	CcSEcCtD
Cefuroxime—Urethral disorder—Epirubicin—breast cancer	0.000245	0.000245	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Doxorubicin—breast cancer	0.000243	0.000244	CcSEcCtD
Cefuroxime—Anorexia—Capecitabine—breast cancer	0.000243	0.000243	CcSEcCtD
Cefuroxime—Angiopathy—Methotrexate—breast cancer	0.000242	0.000242	CcSEcCtD
Cefuroxime—Vomiting—Mitoxantrone—breast cancer	0.000242	0.000242	CcSEcCtD
Cefuroxime—Vomiting—Irinotecan—breast cancer	0.000242	0.000242	CcSEcCtD
Cefuroxime—Sinusitis—Doxorubicin—breast cancer	0.000241	0.000242	CcSEcCtD
Cefuroxime—Immune system disorder—Methotrexate—breast cancer	0.000241	0.000241	CcSEcCtD
Cefuroxime—Dizziness—Fluorouracil—breast cancer	0.000241	0.000241	CcSEcCtD
Cefuroxime—Agranulocytosis—Doxorubicin—breast cancer	0.00024	0.00024	CcSEcCtD
Cefuroxime—Rash—Mitoxantrone—breast cancer	0.00024	0.00024	CcSEcCtD
Cefuroxime—Rash—Irinotecan—breast cancer	0.00024	0.00024	CcSEcCtD
Cefuroxime—Dermatitis—Mitoxantrone—breast cancer	0.00024	0.00024	CcSEcCtD
Cefuroxime—Dermatitis—Irinotecan—breast cancer	0.00024	0.00024	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Docetaxel—breast cancer	0.00024	0.00024	CcSEcCtD
Cefuroxime—Chills—Methotrexate—breast cancer	0.000239	0.00024	CcSEcCtD
Cefuroxime—Headache—Mitoxantrone—breast cancer	0.000238	0.000239	CcSEcCtD
Cefuroxime—Headache—Irinotecan—breast cancer	0.000238	0.000239	CcSEcCtD
Cefuroxime—Erythema multiforme—Epirubicin—breast cancer	0.000236	0.000236	CcSEcCtD
Cefuroxime—Vomiting—Gemcitabine—breast cancer	0.000236	0.000236	CcSEcCtD
Cefuroxime—Dyspnoea—Docetaxel—breast cancer	0.000234	0.000235	CcSEcCtD
Cefuroxime—Somnolence—Docetaxel—breast cancer	0.000234	0.000234	CcSEcCtD
Cefuroxime—Rash—Gemcitabine—breast cancer	0.000234	0.000234	CcSEcCtD
Cefuroxime—Dermatitis—Gemcitabine—breast cancer	0.000233	0.000234	CcSEcCtD
Cefuroxime—Erythema—Methotrexate—breast cancer	0.000232	0.000233	CcSEcCtD
Cefuroxime—Haemoglobin—Doxorubicin—breast cancer	0.000232	0.000233	CcSEcCtD
Cefuroxime—Headache—Gemcitabine—breast cancer	0.000232	0.000232	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000232	0.000232	CcSEcCtD
Cefuroxime—Vomiting—Fluorouracil—breast cancer	0.000232	0.000232	CcSEcCtD
Cefuroxime—Dyspepsia—Docetaxel—breast cancer	0.000231	0.000232	CcSEcCtD
Cefuroxime—Haemorrhage—Doxorubicin—breast cancer	0.000231	0.000231	CcSEcCtD
Cefuroxime—Hepatitis—Doxorubicin—breast cancer	0.000231	0.000231	CcSEcCtD
Cefuroxime—Rash—Fluorouracil—breast cancer	0.00023	0.00023	CcSEcCtD
Cefuroxime—Dermatitis—Fluorouracil—breast cancer	0.00023	0.00023	CcSEcCtD
Cefuroxime—Decreased appetite—Docetaxel—breast cancer	0.000229	0.000229	CcSEcCtD
Cefuroxime—Hypersensitivity—Paclitaxel—breast cancer	0.000229	0.000229	CcSEcCtD
Cefuroxime—Headache—Fluorouracil—breast cancer	0.000228	0.000229	CcSEcCtD
Cefuroxime—Urinary tract disorder—Doxorubicin—breast cancer	0.000228	0.000228	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Docetaxel—breast cancer	0.000227	0.000227	CcSEcCtD
Cefuroxime—Dyspnoea—Capecitabine—breast cancer	0.000227	0.000227	CcSEcCtD
Cefuroxime—Angiopathy—Epirubicin—breast cancer	0.000227	0.000227	CcSEcCtD
Cefuroxime—Urethral disorder—Doxorubicin—breast cancer	0.000226	0.000227	CcSEcCtD
Cefuroxime—Nausea—Mitoxantrone—breast cancer	0.000226	0.000226	CcSEcCtD
Cefuroxime—Nausea—Irinotecan—breast cancer	0.000226	0.000226	CcSEcCtD
Cefuroxime—Immune system disorder—Epirubicin—breast cancer	0.000226	0.000226	CcSEcCtD
Cefuroxime—Pain—Docetaxel—breast cancer	0.000225	0.000225	CcSEcCtD
Cefuroxime—Dyspepsia—Capecitabine—breast cancer	0.000224	0.000224	CcSEcCtD
Cefuroxime—Chills—Epirubicin—breast cancer	0.000224	0.000224	CcSEcCtD
Cefuroxime—Decreased appetite—Capecitabine—breast cancer	0.000221	0.000222	CcSEcCtD
Cefuroxime—Nausea—Gemcitabine—breast cancer	0.00022	0.00022	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Capecitabine—breast cancer	0.00022	0.00022	CcSEcCtD
Cefuroxime—Pruritus—Paclitaxel—breast cancer	0.00022	0.00022	CcSEcCtD
Cefuroxime—Erythema multiforme—Doxorubicin—breast cancer	0.000218	0.000219	CcSEcCtD
Cefuroxime—Pain—Capecitabine—breast cancer	0.000218	0.000218	CcSEcCtD
Cefuroxime—Erythema—Epirubicin—breast cancer	0.000217	0.000218	CcSEcCtD
Cefuroxime—Nausea—Fluorouracil—breast cancer	0.000216	0.000217	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Docetaxel—breast cancer	0.000215	0.000215	CcSEcCtD
Cefuroxime—Flatulence—Epirubicin—breast cancer	0.000214	0.000214	CcSEcCtD
Cefuroxime—Diarrhoea—Paclitaxel—breast cancer	0.000212	0.000213	CcSEcCtD
Cefuroxime—Angiopathy—Doxorubicin—breast cancer	0.00021	0.00021	CcSEcCtD
Cefuroxime—Muscle spasms—Epirubicin—breast cancer	0.000209	0.000209	CcSEcCtD
Cefuroxime—Immune system disorder—Doxorubicin—breast cancer	0.000209	0.000209	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Capecitabine—breast cancer	0.000208	0.000208	CcSEcCtD
Cefuroxime—Body temperature increased—Docetaxel—breast cancer	0.000208	0.000208	CcSEcCtD
Cefuroxime—Abdominal pain—Docetaxel—breast cancer	0.000208	0.000208	CcSEcCtD
Cefuroxime—Leukopenia—Methotrexate—breast cancer	0.000208	0.000208	CcSEcCtD
Cefuroxime—Chills—Doxorubicin—breast cancer	0.000207	0.000208	CcSEcCtD
Cefuroxime—Dizziness—Paclitaxel—breast cancer	0.000205	0.000205	CcSEcCtD
Cefuroxime—Cough—Methotrexate—breast cancer	0.000203	0.000203	CcSEcCtD
Cefuroxime—Urticaria—Capecitabine—breast cancer	0.000202	0.000203	CcSEcCtD
Cefuroxime—Cefradine—CYP3A4—breast cancer	0.000202	0.152	CrCbGaD
Cefuroxime—Abdominal pain—Capecitabine—breast cancer	0.000201	0.000202	CcSEcCtD
Cefuroxime—Body temperature increased—Capecitabine—breast cancer	0.000201	0.000202	CcSEcCtD
Cefuroxime—Convulsion—Methotrexate—breast cancer	0.000201	0.000201	CcSEcCtD
Cefuroxime—Erythema—Doxorubicin—breast cancer	0.000201	0.000201	CcSEcCtD
Cefuroxime—Agitation—Epirubicin—breast cancer	0.0002	0.0002	CcSEcCtD
Cefuroxime—Flatulence—Doxorubicin—breast cancer	0.000198	0.000198	CcSEcCtD
Cefuroxime—Arthralgia—Methotrexate—breast cancer	0.000198	0.000198	CcSEcCtD
Cefuroxime—Chest pain—Methotrexate—breast cancer	0.000198	0.000198	CcSEcCtD
Cefuroxime—Vomiting—Paclitaxel—breast cancer	0.000197	0.000198	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000196	0.000197	CcSEcCtD
Cefuroxime—Rash—Paclitaxel—breast cancer	0.000196	0.000196	CcSEcCtD
Cefuroxime—Dermatitis—Paclitaxel—breast cancer	0.000195	0.000196	CcSEcCtD
Cefuroxime—Leukopenia—Epirubicin—breast cancer	0.000195	0.000195	CcSEcCtD
Cefuroxime—Headache—Paclitaxel—breast cancer	0.000194	0.000195	CcSEcCtD
Cefuroxime—Hypersensitivity—Docetaxel—breast cancer	0.000194	0.000194	CcSEcCtD
Cefuroxime—Muscle spasms—Doxorubicin—breast cancer	0.000193	0.000194	CcSEcCtD
Cefuroxime—Palpitations—Epirubicin—breast cancer	0.000192	0.000192	CcSEcCtD
Cefuroxime—Cough—Epirubicin—breast cancer	0.00019	0.00019	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methotrexate—breast cancer	0.00019	0.00019	CcSEcCtD
Cefuroxime—Convulsion—Epirubicin—breast cancer	0.000188	0.000189	CcSEcCtD
Cefuroxime—Hypersensitivity—Capecitabine—breast cancer	0.000188	0.000188	CcSEcCtD
Cefuroxime—Pruritus—Docetaxel—breast cancer	0.000186	0.000186	CcSEcCtD
Cefuroxime—Thrombocytopenia—Methotrexate—breast cancer	0.000186	0.000186	CcSEcCtD
Cefuroxime—Arthralgia—Epirubicin—breast cancer	0.000185	0.000185	CcSEcCtD
Cefuroxime—Chest pain—Epirubicin—breast cancer	0.000185	0.000185	CcSEcCtD
Cefuroxime—Agitation—Doxorubicin—breast cancer	0.000185	0.000185	CcSEcCtD
Cefuroxime—Nausea—Paclitaxel—breast cancer	0.000184	0.000185	CcSEcCtD
Cefuroxime—Skin disorder—Methotrexate—breast cancer	0.000184	0.000184	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000184	0.000184	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methotrexate—breast cancer	0.000183	0.000183	CcSEcCtD
Cefuroxime—Anorexia—Methotrexate—breast cancer	0.000181	0.000181	CcSEcCtD
Cefuroxime—Pruritus—Capecitabine—breast cancer	0.00018	0.00018	CcSEcCtD
Cefuroxime—Leukopenia—Doxorubicin—breast cancer	0.00018	0.00018	CcSEcCtD
Cefuroxime—Diarrhoea—Docetaxel—breast cancer	0.00018	0.00018	CcSEcCtD
Cefuroxime—Palpitations—Doxorubicin—breast cancer	0.000178	0.000178	CcSEcCtD
Cefuroxime—Anaphylactic shock—Epirubicin—breast cancer	0.000177	0.000178	CcSEcCtD
Cefuroxime—Cough—Doxorubicin—breast cancer	0.000175	0.000176	CcSEcCtD
Cefuroxime—Convulsion—Doxorubicin—breast cancer	0.000174	0.000174	CcSEcCtD
Cefuroxime—Diarrhoea—Capecitabine—breast cancer	0.000174	0.000174	CcSEcCtD
Cefuroxime—Dizziness—Docetaxel—breast cancer	0.000174	0.000174	CcSEcCtD
Cefuroxime—Thrombocytopenia—Epirubicin—breast cancer	0.000174	0.000174	CcSEcCtD
Cefuroxime—Tachycardia—Epirubicin—breast cancer	0.000173	0.000173	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000173	0.000173	CcSEcCtD
Cefuroxime—Skin disorder—Epirubicin—breast cancer	0.000172	0.000173	CcSEcCtD
Cefuroxime—Hyperhidrosis—Epirubicin—breast cancer	0.000171	0.000172	CcSEcCtD
Cefuroxime—Arthralgia—Doxorubicin—breast cancer	0.000171	0.000171	CcSEcCtD
Cefuroxime—Chest pain—Doxorubicin—breast cancer	0.000171	0.000171	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.00017	0.00017	CcSEcCtD
Cefuroxime—Anorexia—Epirubicin—breast cancer	0.000169	0.000169	CcSEcCtD
Cefuroxime—Dyspnoea—Methotrexate—breast cancer	0.000169	0.000169	CcSEcCtD
Cefuroxime—Somnolence—Methotrexate—breast cancer	0.000169	0.000169	CcSEcCtD
Cefuroxime—Dizziness—Capecitabine—breast cancer	0.000168	0.000169	CcSEcCtD
Cefuroxime—Vomiting—Docetaxel—breast cancer	0.000167	0.000167	CcSEcCtD
Cefuroxime—Dyspepsia—Methotrexate—breast cancer	0.000167	0.000167	CcSEcCtD
Cefuroxime—Rash—Docetaxel—breast cancer	0.000166	0.000166	CcSEcCtD
Cefuroxime—Dermatitis—Docetaxel—breast cancer	0.000166	0.000166	CcSEcCtD
Cefuroxime—Decreased appetite—Methotrexate—breast cancer	0.000165	0.000165	CcSEcCtD
Cefuroxime—Headache—Docetaxel—breast cancer	0.000165	0.000165	CcSEcCtD
Cefuroxime—Anaphylactic shock—Doxorubicin—breast cancer	0.000164	0.000164	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Methotrexate—breast cancer	0.000164	0.000164	CcSEcCtD
Cefuroxime—Pain—Methotrexate—breast cancer	0.000162	0.000162	CcSEcCtD
Cefuroxime—Vomiting—Capecitabine—breast cancer	0.000162	0.000162	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000162	0.000162	CcSEcCtD
Cefuroxime—Thrombocytopenia—Doxorubicin—breast cancer	0.000161	0.000161	CcSEcCtD
Cefuroxime—Rash—Capecitabine—breast cancer	0.000161	0.000161	CcSEcCtD
Cefuroxime—Dermatitis—Capecitabine—breast cancer	0.00016	0.000161	CcSEcCtD
Cefuroxime—Tachycardia—Doxorubicin—breast cancer	0.00016	0.00016	CcSEcCtD
Cefuroxime—Headache—Capecitabine—breast cancer	0.00016	0.00016	CcSEcCtD
Cefuroxime—Skin disorder—Doxorubicin—breast cancer	0.000159	0.00016	CcSEcCtD
Cefuroxime—Hyperhidrosis—Doxorubicin—breast cancer	0.000159	0.000159	CcSEcCtD
Cefuroxime—Dyspnoea—Epirubicin—breast cancer	0.000158	0.000158	CcSEcCtD
Cefuroxime—Somnolence—Epirubicin—breast cancer	0.000158	0.000158	CcSEcCtD
Cefuroxime—Anorexia—Doxorubicin—breast cancer	0.000156	0.000157	CcSEcCtD
Cefuroxime—Nausea—Docetaxel—breast cancer	0.000156	0.000156	CcSEcCtD
Cefuroxime—Dyspepsia—Epirubicin—breast cancer	0.000156	0.000156	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methotrexate—breast cancer	0.000155	0.000155	CcSEcCtD
Cefuroxime—Decreased appetite—Epirubicin—breast cancer	0.000154	0.000154	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Epirubicin—breast cancer	0.000153	0.000153	CcSEcCtD
Cefuroxime—Cephalexin—CYP2D6—breast cancer	0.000152	0.115	CrCbGaD
Cefuroxime—Pain—Epirubicin—breast cancer	0.000152	0.000152	CcSEcCtD
Cefuroxime—Nausea—Capecitabine—breast cancer	0.000151	0.000151	CcSEcCtD
Cefuroxime—Cefazolin—ALB—breast cancer	0.000151	0.114	CrCbGaD
Cefuroxime—Urticaria—Methotrexate—breast cancer	0.000151	0.000151	CcSEcCtD
Cefuroxime—Abdominal pain—Methotrexate—breast cancer	0.00015	0.00015	CcSEcCtD
Cefuroxime—Body temperature increased—Methotrexate—breast cancer	0.00015	0.00015	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.00015	0.00015	CcSEcCtD
Cefuroxime—Dyspnoea—Doxorubicin—breast cancer	0.000146	0.000147	CcSEcCtD
Cefuroxime—Somnolence—Doxorubicin—breast cancer	0.000146	0.000146	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Epirubicin—breast cancer	0.000145	0.000145	CcSEcCtD
Cefuroxime—Dyspepsia—Doxorubicin—breast cancer	0.000144	0.000145	CcSEcCtD
Cefuroxime—Ceftriaxone—ALB—breast cancer	0.000143	0.108	CrCbGaD
Cefuroxime—Decreased appetite—Doxorubicin—breast cancer	0.000143	0.000143	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000142	0.000142	CcSEcCtD
Cefuroxime—Urticaria—Epirubicin—breast cancer	0.000141	0.000141	CcSEcCtD
Cefuroxime—Pain—Doxorubicin—breast cancer	0.00014	0.000141	CcSEcCtD
Cefuroxime—Abdominal pain—Epirubicin—breast cancer	0.00014	0.00014	CcSEcCtD
Cefuroxime—Body temperature increased—Epirubicin—breast cancer	0.00014	0.00014	CcSEcCtD
Cefuroxime—Hypersensitivity—Methotrexate—breast cancer	0.00014	0.00014	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Doxorubicin—breast cancer	0.000134	0.000134	CcSEcCtD
Cefuroxime—Pruritus—Methotrexate—breast cancer	0.000134	0.000134	CcSEcCtD
Cefuroxime—Hypersensitivity—Epirubicin—breast cancer	0.000131	0.000131	CcSEcCtD
Cefuroxime—Cephalexin—CYP3A4—breast cancer	0.00013	0.0983	CrCbGaD
Cefuroxime—Urticaria—Doxorubicin—breast cancer	0.00013	0.000131	CcSEcCtD
Cefuroxime—Abdominal pain—Doxorubicin—breast cancer	0.00013	0.00013	CcSEcCtD
Cefuroxime—Body temperature increased—Doxorubicin—breast cancer	0.00013	0.00013	CcSEcCtD
Cefuroxime—Diarrhoea—Methotrexate—breast cancer	0.00013	0.00013	CcSEcCtD
Cefuroxime—Pruritus—Epirubicin—breast cancer	0.000125	0.000126	CcSEcCtD
Cefuroxime—Dizziness—Methotrexate—breast cancer	0.000125	0.000126	CcSEcCtD
Cefuroxime—Cefalotin—ALB—breast cancer	0.000125	0.0943	CrCbGaD
Cefuroxime—Diarrhoea—Epirubicin—breast cancer	0.000121	0.000122	CcSEcCtD
Cefuroxime—Hypersensitivity—Doxorubicin—breast cancer	0.000121	0.000121	CcSEcCtD
Cefuroxime—Vomiting—Methotrexate—breast cancer	0.000121	0.000121	CcSEcCtD
Cefuroxime—Rash—Methotrexate—breast cancer	0.00012	0.00012	CcSEcCtD
Cefuroxime—Dermatitis—Methotrexate—breast cancer	0.000119	0.00012	CcSEcCtD
Cefuroxime—Headache—Methotrexate—breast cancer	0.000119	0.000119	CcSEcCtD
Cefuroxime—Dizziness—Epirubicin—breast cancer	0.000117	0.000117	CcSEcCtD
Cefuroxime—Pruritus—Doxorubicin—breast cancer	0.000116	0.000116	CcSEcCtD
Cefuroxime—Cephalexin—ALB—breast cancer	0.000114	0.0857	CrCbGaD
Cefuroxime—Vomiting—Epirubicin—breast cancer	0.000113	0.000113	CcSEcCtD
Cefuroxime—Nausea—Methotrexate—breast cancer	0.000113	0.000113	CcSEcCtD
Cefuroxime—Diarrhoea—Doxorubicin—breast cancer	0.000112	0.000112	CcSEcCtD
Cefuroxime—Rash—Epirubicin—breast cancer	0.000112	0.000112	CcSEcCtD
Cefuroxime—Dermatitis—Epirubicin—breast cancer	0.000112	0.000112	CcSEcCtD
Cefuroxime—Headache—Epirubicin—breast cancer	0.000111	0.000111	CcSEcCtD
Cefuroxime—Dizziness—Doxorubicin—breast cancer	0.000109	0.000109	CcSEcCtD
Cefuroxime—Nausea—Epirubicin—breast cancer	0.000105	0.000106	CcSEcCtD
Cefuroxime—Vomiting—Doxorubicin—breast cancer	0.000104	0.000104	CcSEcCtD
Cefuroxime—Rash—Doxorubicin—breast cancer	0.000103	0.000104	CcSEcCtD
Cefuroxime—Dermatitis—Doxorubicin—breast cancer	0.000103	0.000104	CcSEcCtD
Cefuroxime—Headache—Doxorubicin—breast cancer	0.000103	0.000103	CcSEcCtD
Cefuroxime—Nausea—Doxorubicin—breast cancer	9.75e-05	9.76e-05	CcSEcCtD
